Stereotaxis Inc (STXS) Stock Price, Quote & News

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed t...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 314 678 6100

Website: www.stereotaxis.com

Address:

710 North Tucker Boulevard, Suite 110, Saint Louis, United States

DonCorleone77 Jul. 16 at 1:01 AM

$ASTS $ACH $STXS $MATX AFTER-HOURS MOVERS: Currently Higher After Earnings: - J.B. Hunt Transport Services (JBHT) up 7.9% - Home BancShares (HOMB) up 2.4% - Great Southern Bancorp (GSBC) up 2.0% Currently Lower After Earnings: - Frequency Electronics (FEIM) down 8.3% - United Airlines (UAL) down 2.4% Currently Also Lower: - AST SpaceMobile (ASTS) down 12.5% after convertible note offering - Accendra Health (ACH) down 3.4% after mixed shelf offering - Stereotaxis (STXS) down 2.5% after equity offering - Matson (MATX) down 0.9% after Q2 pre-announcement.

0 · Reply

zbenz Jul. 16 at 12:33 AM

$STXS https://www.sec.gov/Archives/edgar/data/1289340/000149315226033398/forms-3.htm#m_006

0 · Reply

brunoq14 Jul. 14 at 6:33 PM

$STXS Current revenue and earnings consensus for Q2 is $8.35M and ($0.05). Key will be whether the bullish outlook for the rest of the year is reiterated.

1 · Reply

jacksonjohn750 Jul. 13 at 4:17 PM

$STXS lowered by limit order to .95

0 · Reply

Blankodiablo Jul. 13 at 3:53 PM

$STXS Down with the ship

2 · Reply

no_ego Jul. 9 at 11:16 PM

$STXS I really don't trust this company at all. If their Magic was really any good, you'd hear about it.

0 · Reply

Eddypgil Jul. 9 at 6:14 PM

$STXS what’s the cash position now? If they have a reliable catheter supplier they should be able to survive on GenesisX sales and catheter sales.

2 · Reply

Eddypgil Jul. 9 at 5:56 PM

$STXS investors don’t know what is going to happen until after it happens. Daily fluctuations in price mean nothing about the company

0 · Reply

brunoq14 Jul. 9 at 5:30 PM

$STXS On the occasion of the Robocath closing (07/09/2026), CEO Fischel referred to technology and strategy, but I particularly liked the mention of "attractive commercial synergies in an expanded addressable market."

1 · Reply

jacksonjohn750 Jul. 9 at 5:10 PM

$STXS just placed the order to buy Alex's shares at .99

0 · Reply

Stereotaxis files to sell 108.87M shares of common stock for holders

2026-07-15T21:25:18.000Z - 5 hours ago

Stereotaxis files to sell 19.45M shares of common stock for holders

Jul 9, 2026, 8:08 AM EDT - 6 days ago

Stereotaxis Completes Acquisition of Robocath

2026-07-01T20:10:17.000Z - 14 days ago

Stereotaxis management to meet with BTIG

Jun 23, 2026, 7:00 AM EDT - 22 days ago

Stereotaxis Slides: Investor presentation

2026-05-13T11:19:51.000Z - 2 months ago

Stereotaxis price target lowered to $3.50 from $4 at Piper Sandler

JNJ

May 12, 2026, 4:30 PM EDT - 2 months ago

Stereotaxis Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 2 months ago

Stereotaxis Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 2 months ago

Stereotaxis Quarterly report: Q1 2026

May 12, 2026, 4:06 PM EDT - 2 months ago

Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates

Apr 22, 2026, 7:58 AM EDT - 3 months ago

Stereotaxis Announces First MAGiC Procedures in the United States

Apr 21, 2026, 9:01 AM EDT - 3 months ago

Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026

Apr 15, 2026, 9:00 AM EDT - 3 months ago

Stereotaxis Transcript: M&A announcement

Apr 15, 2026, 9:00 AM EDT - 3 months ago

Stereotaxis Press release: M&A announcement

2026-04-15T11:12:19.000Z - 3 months ago

Stereotaxis to acquire Robocath, terms undisclosed

Apr 15, 2026, 7:00 AM EDT - 3 months ago

Stereotaxis Announces Definitive Agreement to Acquire Robocath

2026-04-06T12:40:34.000Z - 3 months ago

Stereotaxis receives FDA clearance for Synchrony system

Apr 6, 2026, 8:06 AM EDT - 3 months ago

Stereotaxis Announces FDA Clearance and Launch of Synchrony System

Apr 3, 2026, 8:00 AM EDT - 3 months ago

Stereotaxis Proxy statement: Proxy filing

Apr 3, 2026, 8:00 AM EDT - 3 months ago

Stereotaxis Proxy statement: Proxy filing

2026-03-13T20:30:19.000Z - 4 months ago

Stereotaxis files $100M mixed securities shelf

2026-03-13T19:35:41.000Z - 4 months ago

Stereotaxis management to meet virtually with BTIG

Mar 13, 2026, 8:00 AM EDT - 4 months ago

Stereotaxis Registration statement: Registration Filing

Mar 9, 2026, 4:30 PM EDT - 4 months ago

Stereotaxis Earnings Call Transcript: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

Stereotaxis Annual report: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

Stereotaxis Earnings release: Q4 2025

2026-03-09T20:05:19.000Z - 4 months ago

Stereotaxis reports Q4 EPS (6c), consensus (6c)

2026-03-09T20:05:10.000Z - 4 months ago

Stereotaxis sees FY26 revenue up double digits

Mar 9, 2026, 4:01 PM EDT - 4 months ago

Stereotaxis Reports 2025 Full Year Financial Results

Feb 12, 2026, 9:00 AM EST - 5 months ago

Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026

2026-02-09T13:37:08.000Z - 5 months ago

Stereotaxis announces launch of electrophysiology program at Klinikum Furth

Feb 9, 2026, 8:06 AM EST - 5 months ago

Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program

2026-01-06T13:39:16.000Z - 6 months ago

Stereotaxis reports FDA approval for MAGiC Ablation Catheter

Jan 6, 2026, 8:01 AM EST - 6 months ago

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

2025-12-16T09:40:34.000Z - 7 months ago

Stereotaxis initiated with an Outperform at Citizens

Nov 24, 2025, 8:58 AM EST - 8 months ago

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

Nov 11, 2025, 4:30 PM EST - 8 months ago

Stereotaxis Earnings Call Transcript: Q3 2025

Nov 11, 2025, 4:30 PM EST - 8 months ago

Stereotaxis Quarterly report: Q3 2025

Nov 11, 2025, 4:30 PM EST - 8 months ago

Stereotaxis Earnings release: Q3 2025

2025-11-11T21:05:25.000Z - 8 months ago

Stereotaxis reports Q3 EPS (7c), consensus (6c)

Nov 11, 2025, 4:01 PM EST - 8 months ago

Stereotaxis Reports 2025 Third Quarter Financial Results

2025-11-10T22:01:01.000Z - 8 months ago

Stereotaxis announces FDA clearance for GenesisX

Nov 10, 2025, 4:05 PM EST - 8 months ago

GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance

2025-11-05T09:25:11.000Z - 9 months ago

Stereotaxis resumed with a Buy at Roth Capital

Oct 21, 2025, 9:00 AM EDT - 9 months ago

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

2025-10-15T11:35:16.000Z - 9 months ago

Stereotaxis announces EU launch, 510k submission for Synchrony system

Oct 15, 2025, 7:32 AM EDT - 9 months ago

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

2025-10-13T11:46:17.000Z - 9 months ago

Stereotaxis, CardioFocus collaborate to advance robotic PFA technology

Oct 13, 2025, 7:34 AM EDT - 9 months ago

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

2025-09-22T12:00:15.000Z - 10 months ago

Stereotaxis announces procedures using Genesis at Erasmus Medical Center

DonCorleone77 Jul. 16 at 1:01 AM

0 · Reply

zbenz Jul. 16 at 12:33 AM

$STXS https://www.sec.gov/Archives/edgar/data/1289340/000149315226033398/forms-3.htm#m_006

0 · Reply

brunoq14 Jul. 14 at 6:33 PM

$STXS Current revenue and earnings consensus for Q2 is $8.35M and ($0.05). Key will be whether the bullish outlook for the rest of the year is reiterated.

1 · Reply

jacksonjohn750 Jul. 13 at 4:17 PM

$STXS lowered by limit order to .95

0 · Reply

Blankodiablo Jul. 13 at 3:53 PM

$STXS Down with the ship

2 · Reply

no_ego Jul. 9 at 11:16 PM

$STXS I really don't trust this company at all. If their Magic was really any good, you'd hear about it.

0 · Reply

Eddypgil Jul. 9 at 6:14 PM

$STXS what’s the cash position now? If they have a reliable catheter supplier they should be able to survive on GenesisX sales and catheter sales.

2 · Reply

Eddypgil Jul. 9 at 5:56 PM

$STXS investors don’t know what is going to happen until after it happens. Daily fluctuations in price mean nothing about the company

0 · Reply

brunoq14 Jul. 9 at 5:30 PM

1 · Reply

jacksonjohn750 Jul. 9 at 5:10 PM

$STXS just placed the order to buy Alex's shares at .99

0 · Reply

jacksonjohn750 Jul. 9 at 2:44 PM

$STXS always Kmart blue light on!

0 · Reply

Georges8792 Jul. 9 at 1:17 PM

$STXS how did they pay for it?

3 · Reply

zbenz Jul. 9 at 1:04 PM

$STXS another expense line item on income stat with no foreseable ROI

0 · Reply

focafoca99 Jul. 9 at 12:17 PM

$STXS finalized its acquisition of Robocath, completing the deal to expand its robotic endovascular platform.

0 · Reply

alexpitti Jul. 7 at 8:46 PM

i sold my adobe thankfully. trading is always stressful. back to the ole barn with my long term holds in $STXS $ABEO $DCTH $MIST

1 · Reply

zbenz Jul. 6 at 7:39 PM

$STXS any clues on big volume today

1 · Reply

bigshipper Jul. 6 at 6:09 PM

$STXS probably 2x volume today

0 · Reply

alexpitti Jul. 5 at 4:32 PM

stereotaxis has their first new slide deck in my over 5 years invested. this signals the innvation plan is coming together and 2027 will be a breakout year $STXS https://ir.stereotaxis.com/static-files/f52b2401-fe8f-4957-843d-c4ccf610c3eb

1 · Reply

zbenz Jul. 3 at 1:58 PM

$STXS so if you think they are buyers ...isn't that a good thing? especially since they hav BOD rep

0 · Reply

Forenzi Jul. 3 at 3:30 AM

$STXS arbiter is one of the biggest holders !

0 · Reply

alexpitti Jul. 2 at 10:22 PM

happy 4th of july $STXS $DCTH $ABEO $ADBE $MIST

3 · Reply

zbenz Jul. 2 at 12:54 PM

$STXS who's Arbiter? , can you please explain you post with a bit more detail for us newbies

2 · Reply

Market Cap	156.38M
Revenue (ttm)	32.38M
Net Income (ttm)	-21.64M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-66.83%
Debt to Equity Ratio	0.00

Volume	655,100
Avg Vol	485,152
Day's Range	N/A - N/A
Shares Out	97.74M
Stochastic %K	9%
Beta	1.34
Analysts	Strong Sell
Price Target	$4.12